BRIEF—WHO seeks to align biowaiver policy with the ICH guide

The World Health Organization (WHO) is seeking to align its biowaiver policy with the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guide.

This effort aims to harmonize global regulatory standards and facilitate the acceptance of biowaivers for certain pharmaceutical products.

By aligning with the ICH guide, the WHO aims to streamline the drug development process and enhance access to safe and effective medicines. This initiative underscores the importance of global collaboration and standardization in advancing public health.

For more information about this development, use this  link!